{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:43:36Z","timestamp":1781667816732,"version":"3.54.5"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thrombosis associated with thrombocytopaenia is an apparent paradox that is present across a wide spectrum of disorders. While thrombocytopaenia has been a controversial clinical classification criterion for APS, as initial reports failed to demonstrate a relation between low platelet count with other clinical or laboratory manifestations of the syndrome, recent data highlight the association between mild\u2013moderate thrombocytopaenia and the risk of thrombosis. Although aPL antibodies may induce platelet activation in vitro, additional stimuli may contribute to their activation in vivo, among which are reactive oxygen and nitrogen species and lipid peroxidation products, which are elevated in patients with APS; an excess of the same stimuli may induce megakaryocyte and platelet apoptosis that leads to decreased platelet production and increased destruction, resulting ultimately in thrombocytopaenia. Herein we provide a novel plausible framework involving free radicals that could add to the understanding of the thrombocytopaenia\u2013thrombosis paradox in APS.<\/jats:p>","DOI":"10.1093\/rheumatology\/keac650","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T12:30:03Z","timestamp":1668688203000},"page":"2070-2075","source":"Crossref","is-referenced-by-count":11,"title":["Thrombocytopaenia in antiphospholipid syndrome: a free radical perspective"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0165-9651","authenticated-orcid":false,"given":"Paul R J","family":"Ames","sequence":"first","affiliation":[{"name":"Department of Haematology, Immune Response and Vascular Disease Unit, Nova University Lisbon , Lisbon, Portugal"},{"name":"Department of Haematology, Dumfries Royal Infirmary , Cargenbridge, Dumfries, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Bucci","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Surgical Specialties and Organ Transplantation \u201cParide Stefanini\u201d, Sapienza University of Rome , Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Merashli","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, American University of Beirut , Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Arcaro","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Sciences \u201cV. Tiberio\u201d, University of Molise , Campobasso, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Gentile","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Sciences \u201cV. Tiberio\u201d, University of Molise , Campobasso, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"2023060113244400900_keac650-B1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/rheumatology\/keab475","article-title":"Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study","volume":"61","author":"Pardos-Gea","year":"2022","journal-title":"Rheumatology"},{"key":"2023060113244400900_keac650-B2","article-title":"Thrombocytopenia in primary antiphospholipid syndrome: association with prognosis and clinical implications","volume":"62","author":"Shi","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2023060113244400900_keac650-B3","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/jth.13763","article-title":"Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study","volume":"15","author":"Hisada","year":"2017","journal-title":"J Thromb Haemost"},{"key":"2023060113244400900_keac650-B4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejim.2020.10.011","article-title":"Risk of thrombosis, pregnancy morbidity or death in antiphospholipid antibodies positive patients with or without thrombocytopenia","volume":"84","author":"Moulinet","year":"2021","journal-title":"Eur J Intern Med"},{"key":"2023060113244400900_keac650-B5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ejh.12777","article-title":"Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis","volume":"97","author":"Doobaree","year":"2016","journal-title":"Eur J Haematol"},{"key":"2023060113244400900_keac650-B6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.thromres.2019.04.016","article-title":"Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia \u2013 results from two nationwide cohorts","volume":"178","author":"Ekstrand","year":"2019","journal-title":"Thromb Res"},{"key":"2023060113244400900_keac650-B7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2015.11.001","article-title":"Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: a systematic review and meta-analysis","volume":"15","author":"Moulis","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2023060113244400900_keac650-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2017.10.001","article-title":"Megakaryocyte and polyploidization","volume":"57","author":"Mazzi","year":"2018","journal-title":"Exp Hematol"},{"key":"2023060113244400900_keac650-B9","doi-asserted-by":"crossref","first-page":"e20191206","DOI":"10.1084\/jem.20191206","article-title":"Membrane budding is a major mechanism of in vivo platelet biogenesis","volume":"217","author":"Potts","year":"2020","journal-title":"J Exp Med"},{"key":"2023060113244400900_keac650-B10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1083\/jcb.201006102","article-title":"Cytoskeletal mechanics of proplatelet maturation and platelet release","volume":"191","author":"Thon","year":"2010","journal-title":"J. Cell Biol"},{"key":"2023060113244400900_keac650-B11","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1002\/jcp.24071","article-title":"Oxidases and reactive oxygen species during hematopoiesis: a focus on megakaryocytes","volume":"227","author":"Eliades","year":"2012","journal-title":"J Cell Physiol"},{"key":"2023060113244400900_keac650-B12","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.3390\/ijms21207591","article-title":"Regulation of platelet production and life span: role of Bcl-xL and potential implications for human platelet diseases","volume":"21","author":"Josefsson","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2023060113244400900_keac650-B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2004.04.032","article-title":"Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells","volume":"337","author":"Boonstra","year":"2004","journal-title":"Gene"},{"key":"2023060113244400900_keac650-B14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12185-011-0872-1","article-title":"Reactive oxygen species and hematopoietic stem cell senescence","volume":"94","author":"Shao","year":"2011","journal-title":"Int J Hematol"},{"key":"2023060113244400900_keac650-B15","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood.V95.11.3451","article-title":"Nitric oxide induces apoptosis in megakaryocytic cell lines","volume":"95","author":"Battinelli","year":"2000","journal-title":"Blood"},{"key":"2023060113244400900_keac650-B16","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3899\/jrheum.100494","article-title":"Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome","volume":"37","author":"Ames","year":"2010","journal-title":"J Rheumatol"},{"key":"2023060113244400900_keac650-B17","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/art.27442","article-title":"Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity","volume":"62","author":"Wang","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2023060113244400900_keac650-B18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1067\/mlc.2001.113659","article-title":"Effect of nitric oxide on megakaryocyte growth induced by thrombopoietin","volume":"137","author":"Schattner","year":"2001","journal-title":"J Lab Clin Med"},{"key":"2023060113244400900_keac650-B19","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2007-12-125906","article-title":"Interferon-\u03b1 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes","volume":"112","author":"Yamane","year":"2008","journal-title":"Blood"},{"key":"2023060113244400900_keac650-B20","doi-asserted-by":"crossref","first-page":"e000260","DOI":"10.1136\/lupus-2018-000260","article-title":"TNF-\u03b1 and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus","volume":"5","author":"Idborg","year":"2018","journal-title":"Lupus Sci Med"},{"key":"2023060113244400900_keac650-B21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2023060113244400900_keac650-B22","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","article-title":"Interferon target-gene expression and epigenomic signatures in health and disease","volume":"20","author":"Barrat","year":"2019","journal-title":"Nat Immunol"},{"key":"2023060113244400900_keac650-B23","doi-asserted-by":"crossref","first-page":"e0208132","DOI":"10.1371\/journal.pone.0208132","article-title":"Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus","volume":"13","author":"Labonte","year":"2018","journal-title":"PLoS One"},{"key":"2023060113244400900_keac650-B24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00296-009-1314-8","article-title":"Increased level of tumor necrosis factor-\u03b1 in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state","volume":"31","author":"Swadzba","year":"2011","journal-title":"Rheumatol Int"},{"key":"2023060113244400900_keac650-B25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic Biol Med"},{"key":"2023060113244400900_keac650-B26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3934\/genet.2017.2.103","article-title":"DNA damage by lipid peroxidation products: implications in cancer, inflammation and autoimmunity","volume":"4","author":"Gentile","year":"2017","journal-title":"AIMS Genet"},{"key":"2023060113244400900_keac650-B27","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1093\/nar\/gkm315","article-title":"Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis","volume":"35","author":"Hinz","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"2023060113244400900_keac650-B28","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood-2014-01-551457","article-title":"Defective endomitosis during megakaryopoiesis leads to thrombocytopenia in Fanca\u2212\/\u2212 mice","volume":"124","author":"Pawlikowska","year":"2014","journal-title":"Blood"},{"key":"2023060113244400900_keac650-B29","doi-asserted-by":"crossref","first-page":"14916","DOI":"10.1074\/jbc.271.25.14916","article-title":"Local amplification of platelet function by 8-epi-prostaglandin-F2-\u03b1 is not mediated by thromboxane receptor isoforms","volume":"271","author":"Pratic\u00f2","year":"1996","journal-title":"J Biol Chem"},{"key":"2023060113244400900_keac650-B30","doi-asserted-by":"crossref","first-page":"102821","DOI":"10.1016\/j.autrev.2021.102821","article-title":"Isoprostanes in systemic lupus erythematosus and antiphospholipid syndrome: a systematic review and meta-analysis","volume":"20","author":"Merashli","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2023060113244400900_keac650-B31","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood.V90.10.3931","article-title":"Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies","volume":"90","author":"Iuliano","year":"1997","journal-title":"Blood"},{"key":"2023060113244400900_keac650-B32","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1182\/blood.V93.10.3401.410k36_3401_3407","article-title":"Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation","volume":"93","author":"Pratic\u00f2","year":"1999","journal-title":"Blood"},{"key":"2023060113244400900_keac650-B33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2141.1994.tb06735.x","article-title":"Evidence for a selective inhibitory effect of thrombin on megakaryocyte progenitor growth mediated by the thrombin receptor","volume":"87","author":"Plantier","year":"1994","journal-title":"Br J Haematol"},{"key":"2023060113244400900_keac650-B34","first-page":"9313269","article-title":"Thrombin maybe plays an important role in MK differentiation into platelets","volume":"2016","author":"Yang","year":"2016","journal-title":"Biomed Res Int"},{"key":"2023060113244400900_keac650-B35","doi-asserted-by":"crossref","first-page":"1076029619853641","DOI":"10.1177\/1076029619853641","article-title":"Platelet apoptosis can be triggered bypassing the death receptors","volume":"25","author":"Leytin","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"2023060113244400900_keac650-B36","doi-asserted-by":"crossref","first-page":"e0203991","DOI":"10.1371\/journal.pone.0203991","article-title":"Role of p53 and transcription-independent p53-induced apoptosis in shear-stimulated megakaryocytic maturation, particle generation, and platelet biogenesis","volume":"13","author":"Luff","year":"2018","journal-title":"PLoS One"},{"key":"2023060113244400900_keac650-B37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40364-021-00346-0","article-title":"The role of phosphatidylserine on the membrane in immunity and blood coagulation","volume":"10","author":"Wang","year":"2022","journal-title":"Biomark Res"},{"key":"2023060113244400900_keac650-B38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/09537104.2021.1988547","article-title":"Pathogenic mechanisms contributing to thrombocytopenia in patients with systemic lupus erythematosus","volume":"33","author":"Baroni Pietto","year":"2022","journal-title":"Platelets"},{"key":"2023060113244400900_keac650-B39","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/rheumatology\/38.6.529","article-title":"Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement","volume":"38","author":"Ames","year":"1999","journal-title":"Rheumatology"},{"key":"2023060113244400900_keac650-B40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1191\/096120398678920163","article-title":"Platelet activation and turnover in the primary antiphospholipid syndrome","volume":"7","author":"Joseph","year":"1998","journal-title":"Lupus"},{"key":"2023060113244400900_keac650-B41","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/rheumatology\/kex216","article-title":"Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus","volume":"56","author":"Lood","year":"2017","journal-title":"Rheumatology"},{"key":"2023060113244400900_keac650-B42","doi-asserted-by":"crossref","first-page":"102437","DOI":"10.1016\/j.jaut.2020.102437","article-title":"Antiphospholipid antibodies can specifically target placental mitochondria and induce ROS production","volume":"111","author":"Zussman","year":"2020","journal-title":"J Autoimmun"},{"key":"2023060113244400900_keac650-B43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7705\/biomedica.4701","article-title":"Oxidative stress in endothelial cells induced by the serum of women with different clinical manifestations of the antiphospholipid syndrome","volume":"39","author":"Vel\u00e1squez","year":"2019","journal-title":"Biomedica"},{"key":"2023060113244400900_keac650-B44","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1160\/TH14-07-0628","article-title":"Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome","volume":"113","author":"M\u00fcller-Calleja","year":"2015","journal-title":"Thromb Haemost"},{"key":"2023060113244400900_keac650-B45","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1089\/ars.2020.8257","article-title":"Loop between NLRP3 inflammasome and reactive oxygen species","volume":"36","author":"Dominic","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"2023060113244400900_keac650-B46","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/jth.14246","article-title":"Tissue factor at the crossroad of coagulation and cell signaling","volume":"16","author":"Zelaya","year":"2018","journal-title":"J Thromb Haemost"},{"key":"2023060113244400900_keac650-B47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaut.2012.05.005","article-title":"Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis","volume":"39","author":"Giannakopoulos","year":"2012","journal-title":"J Autoimmun"},{"key":"2023060113244400900_keac650-B48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijbiomac.2016.05.076","article-title":"The susceptibility of plasma coagulation factor XI to nitration and peroxynitrite action","volume":"91","author":"Ponczek","year":"2016","journal-title":"Int J Biol Macromol"},{"key":"2023060113244400900_keac650-B49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molimm.2004.03.013","article-title":"Initiation of complement activation following oxidative stress. In vitro and in vivo observations","volume":"41","author":"Hart","year":"2004","journal-title":"Mol Immunol"},{"key":"2023060113244400900_keac650-B50","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0002-9440(10)61779-8","article-title":"Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1","volume":"159","author":"Collard","year":"2001","journal-title":"Am J Pathol"},{"key":"2023060113244400900_keac650-B51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.thromres.2017.09.010","article-title":"Coagulation and complement in antiphospholipid syndrome","volume":"158","author":"Ames","year":"2017","journal-title":"Thromb Res"},{"key":"2023060113244400900_keac650-B52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijbiomac.2015.07.059","article-title":"Peroxynitrite and fibrinolytic system-the effects of peroxynitrite on t-PA-induced plasmin activity","volume":"81","author":"Kolodziejczyk-Czepas","year":"2015","journal-title":"Int J Biol Macromol"},{"key":"2023060113244400900_keac650-B53","first-page":"1359","article-title":"Correction of thrombocytopenia with small dose aspirin in the primary antiphospholipid syndrome","volume":"16","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"J Rheumatol"},{"key":"2023060113244400900_keac650-B54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ajh.1182","article-title":"Correction of thrombocytopenia with aspirin in the primary antiphospholipid syndrome","volume":"68","author":"Alliot","year":"2001","journal-title":"Am J Hematol"},{"key":"2023060113244400900_keac650-B55","first-page":"803","article-title":"Multiple complications of the antiphospholipid syndrome with apparent response to aspirin therapy","volume":"19","author":"Cohen","year":"1992","journal-title":"J Rheumatol"},{"key":"2023060113244400900_keac650-B56","first-page":"863","article-title":"La thrombopenie du syndrome primaire des anticorps antiphospholipides est-elle una contre-indication a l\u2019aspirine?","volume":"25","author":"Durand","year":"1996","journal-title":"Presse Med"},{"key":"2023060113244400900_keac650-B57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2007-1003553","article-title":"Acetylation of antithrombin III by aspirin","volume":"12","author":"Villanueva","year":"1986","journal-title":"Semin Thromb Hemost"},{"key":"2023060113244400900_keac650-B58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(02)02925-4","article-title":"Anti-thrombin action of low-dose acetylsalicylic acid","volume":"460","author":"Di Micco","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"2023060113244400900_keac650-B59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0049-3848(98)00126-1","article-title":"Influence of low- and high-dose aspirin treatment on thrombin generation in whole blood","volume":"92","author":"Wall\u00e9n","year":"1998","journal-title":"Thromb Res"},{"key":"2023060113244400900_keac650-B60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/FJC.0000000000000939","article-title":"Chronic application of low-dose aspirin affects multiple parameters of three blood cellular types and antithrombin activity: a 1:1:1 propensity score matching analysis","volume":"77","author":"Li","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"key":"2023060113244400900_keac650-B61","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/096120339500400613","article-title":"Reversal of thrombocytopenia following oral anticoagulation in two patients with primary antiphospholipid syndrome","volume":"4","author":"Ames","year":"1995","journal-title":"Lupus"},{"key":"2023060113244400900_keac650-B62","first-page":"769","article-title":"Thrombocytopenia corrected by warfarin in antiphospholipid syndrome","volume":"23","author":"Wisbey","year":"1996","journal-title":"J Rheumatol"},{"key":"2023060113244400900_keac650-B63","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0735-1097(03)00416-9","article-title":"American Heart Association\/American College of Cardiology Foundation. American Heart Association\/American College of Cardiology Foundation guide to warfarin therapy","volume":"41","author":"Hirsh","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2023060113244400900_keac650-B64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.thromres.2019.03.022","article-title":"Correlation of thromboelastography and thrombin generation assays in warfarin-treated patients","volume":"178","author":"Schmidt","year":"2019","journal-title":"Thromb Res"},{"key":"2023060113244400900_keac650-B65","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/096120339600500116","article-title":"Correction of severe thrombocytopenia with chloroquine in the primary antiphospholipid syndrome","volume":"5","author":"Suarez","year":"1996","journal-title":"Lupus"},{"key":"2023060113244400900_keac650-B66","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1002\/ajh.24698","article-title":"Evaluation of the efficiency of hydroxychloroquine in treating children with immune thrombocytopenia (ITP)","volume":"92","author":"Roche","year":"2017","journal-title":"Am J Hematol"},{"key":"2023060113244400900_keac650-B67","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ajh.23609","article-title":"Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies","volume":"89","author":"Khellaf","year":"2014","journal-title":"Am J Hematol"},{"key":"2023060113244400900_keac650-B68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.intimp.2015.05.048","article-title":"Selective inhibition of extracellular oxidants liberated from human neutrophils-a new mechanism potentially involved in the anti-inflammatory activity of hydroxychloroquine","volume":"28","author":"Jan\u010dinov\u00e1","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"2023060113244400900_keac650-B69","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/annrheumdis-2016-210012","article-title":"Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase","volume":"76","author":"M\u00fcller-Calleja","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023060113244400900_keac650-B70","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3390\/ijms21072504","article-title":"Hydroxychloroquine mitigates the production of 8-isoprostane and improves vascular dysfunction: implications for treating preeclampsia","volume":"21","author":"Rahman","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2023060113244400900_keac650-B71","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-0038-1650552","article-title":"Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies \u2013 a crucial role for acquired free protein S deficiency","volume":"76","author":"Ames","year":"1996","journal-title":"Thromb Haemost"},{"key":"2023060113244400900_keac650-B72","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/antiox9121292","article-title":"Oxidative stress and antioxidant treatments in cardiovascular diseases","volume":"9","author":"Wang","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"2023060113244400900_keac650-B73","doi-asserted-by":"crossref","first-page":"e003553","DOI":"10.1161\/JAHA.116.003553","article-title":"Thrombin generation and atherothrombosis: what does the evidence indicate?","volume":"5","author":"Ten Cate","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2023060113244400900_keac650-B74","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1538-7836.2009.03308.x","article-title":"Atherosclerosis in thrombotic primary antiphospholipid syndrome","volume":"7","author":"Ames","year":"2009","journal-title":"J Thromb Haemost"},{"key":"2023060113244400900_keac650-B75","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/RHU.0b013e31817de0fb","article-title":"Acute myocardial infarction after treatment of thrombocytopenia in a young woman with systemic lupus erythematosus","volume":"14","author":"Tan","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"2023060113244400900_keac650-B76","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/rheumatology\/key119","article-title":"Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists","volume":"57","author":"Guitton","year":"2018","journal-title":"Rheumatology"},{"key":"2023060113244400900_keac650-B77","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.semarthrit.2015.07.008","article-title":"Two cases of thrombosis in patients with antiphospholipid antibodies during treatment of immune thrombocytopenia with romiplostim, a thrombopoietin receptor agonist","volume":"45","author":"LaMoreaux","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2023060113244400900_keac650-B78","article-title":"Two cases of thrombosis in patients with antiphospholipid antibodies during treatment of immune thrombocytopenia with romiplostin, a thrombopoietin receptor agonist","volume":"45","author":"Borrell","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2023060113244400900_keac650-B79","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/0961203315608257","article-title":"Eltrombopag in systemic lupus erythematosus with antiphospholipid syndrome: thrombotic events","volume":"25","author":"Boulon","year":"2016","journal-title":"Lupus"},{"key":"2023060113244400900_keac650-B80","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1038\/s41598-020-59526-x","article-title":"The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli","volume":"10","author":"Chernysh","year":"2020","journal-title":"Sci Rep"},{"key":"2023060113244400900_keac650-B81","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.3390\/cells10123386","article-title":"Platelet activation mechanisms and consequences of immune thrombocytopenia","volume":"10","author":"Sun","year":"2021","journal-title":"Cells"},{"key":"2023060113244400900_keac650-B82","doi-asserted-by":"crossref","first-page":"104408","DOI":"10.1016\/j.phrs.2019.104408","article-title":"Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: association with inflammation, oxidative and nitrosative stress and autoimmune responses","volume":"148","author":"Morris","year":"2019","journal-title":"Pharmacol Res"},{"key":"2023060113244400900_keac650-B83","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1089\/ars.2021.0162","article-title":"Oxidative post-translational modifications: a focus on cysteine S-sulfhydration and the regulation of endothelial fitness","volume":"35","author":"Bibli","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"2023060113244400900_keac650-B84","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1191\/096120300677692516","article-title":"Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study","volume":"9","author":"Ames","year":"2000","journal-title":"Lupus"},{"key":"2023060113244400900_keac650-B85","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/ATVBAHA.117.309225","article-title":"Ubiquinol effects on antiphospholipid syndrome prothrombotic profile: a randomized, placebo-controlled trial","volume":"37","author":"P\u00e9rez-S\u00e1nchez","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac650\/47536519\/keac650.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/6\/2070\/50500842\/keac650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/6\/2070\/50500842\/keac650.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T22:09:02Z","timestamp":1701382142000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/6\/2070\/6832030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":85,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,11,17]]},"published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac650","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,1]]},"published":{"date-parts":[[2022,11,17]]}}}